PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,027,615 | -29.5% | 179,724 | +27.9% | 0.00% | -50.0% |
Q2 2023 | $5,714,216 | +267.2% | 140,502 | +337.3% | 0.00% | +100.0% |
Q1 2023 | $1,556,280 | +443.8% | 32,128 | +328.5% | 0.00% | – |
Q4 2022 | $286,199 | -81.5% | 7,498 | -75.7% | 0.00% | -100.0% |
Q3 2022 | $1,547,000 | -10.0% | 30,820 | -28.2% | 0.00% | 0.0% |
Q2 2022 | $1,719,000 | +136.5% | 42,911 | +120.3% | 0.00% | – |
Q1 2022 | $727,000 | +97.0% | 19,477 | +109.7% | 0.00% | – |
Q4 2021 | $369,000 | -14.4% | 9,290 | -19.7% | 0.00% | – |
Q3 2021 | $431,000 | -34.2% | 11,576 | -25.3% | 0.00% | – |
Q2 2021 | $655,000 | -55.8% | 15,500 | -50.5% | 0.00% | – |
Q1 2021 | $1,482,000 | -32.2% | 31,292 | -12.7% | 0.00% | -100.0% |
Q4 2020 | $2,187,000 | -38.9% | 35,836 | -53.2% | 0.00% | -50.0% |
Q3 2020 | $3,577,000 | -29.3% | 76,507 | -23.2% | 0.00% | -50.0% |
Q2 2020 | $5,058,000 | +1674.7% | 99,681 | +1457.5% | 0.00% | – |
Q1 2020 | $285,000 | -39.2% | 6,400 | -34.4% | 0.00% | -100.0% |
Q4 2019 | $469,000 | -55.9% | 9,756 | -69.0% | 0.00% | -50.0% |
Q3 2019 | $1,064,000 | +383.6% | 31,451 | +542.1% | 0.00% | – |
Q2 2019 | $220,000 | -32.9% | 4,898 | -43.8% | 0.00% | -100.0% |
Q1 2019 | $328,000 | -65.6% | 8,719 | -57.1% | 0.00% | 0.0% |
Q3 2018 | $954,000 | +61.7% | 20,306 | -6.8% | 0.00% | -50.0% |
Q1 2018 | $590,000 | -85.1% | 21,790 | -89.0% | 0.00% | -84.6% |
Q3 2017 | $3,961,000 | +2076.4% | 197,968 | +1085.4% | 0.01% | +1200.0% |
Q4 2016 | $182,000 | -76.9% | 16,700 | -70.3% | 0.00% | -75.0% |
Q3 2016 | $787,000 | +719.8% | 56,200 | +311.1% | 0.00% | – |
Q2 2016 | $96,000 | -80.9% | 13,669 | -82.5% | 0.00% | -100.0% |
Q1 2016 | $502,000 | +141.3% | 77,915 | +1112.7% | 0.00% | +200.0% |
Q4 2015 | $208,000 | -96.1% | 6,425 | -96.8% | 0.00% | -97.0% |
Q3 2015 | $5,289,000 | +1037.4% | 198,100 | +2495.3% | 0.03% | +725.0% |
Q1 2015 | $465,000 | -0.9% | 7,633 | -57.5% | 0.00% | -33.3% |
Q2 2014 | $469,000 | – | 17,947 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |